Airway Clearance Devices for Cystic Fibrosis Market Report 2025

This Airway Clearance Devices For Cystic Fibrosis market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The airway clearance devices for cystic fibrosis market size has grown strongly in recent years. It will grow from $2.59 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to factors such as the increasing prevalence of cystic fibrosis, the expansion of supportive government healthcare policies, improvements in healthcare infrastructure, rising healthcare insurance coverage, and a growing incidence of respiratory diseases.

The airway clearance devices for cystic fibrosis market size is expected to see strong growth in the next few years. It will grow to $3.48 billion in 2029 at a compound annual growth rate (CAGR) of 6%. For the forecast period, growth is expected due to factors such as the increasing incidence of chronic respiratory diseases, the growing geriatric population, the development of combination therapies, rising demand for non-invasive treatments, and the adoption of personalized healthcare. Key trends expected during this period include technological advancements, personalized therapy, wearable devices, combined therapies, and the integration of artificial intelligence.

The growing incidence of lung disorders is anticipated to drive the expansion of the airway clearance devices market for cystic fibrosis in the near future. Lung disorders are conditions that result in the excessive production of mucus and impaired lung function, leading to an increasing demand for effective solutions to clear airways and enhance respiratory health. This rise in lung disorders can be attributed to various interconnected factors, including increased air pollution, smoking, and tobacco consumption, all of which significantly contribute to respiratory diseases and long-term lung damage. Airway clearance devices such as high-frequency chest wall oscillation (HFCWO) vests, positive expiratory pressure (PEP) devices, and oscillatory PEP devices play a crucial role in breaking up and clearing thick mucus from the airways, which is especially beneficial for cystic fibrosis patients who suffer from thick and sticky mucus that causes chronic lung infections and breathing problems. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a rise in tuberculosis cases, from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Thus, the growing prevalence of lung disorders is expected to drive the market for airway clearance devices in cystic fibrosis.

Leading companies in the airway clearance devices market for cystic fibrosis are focusing on technological innovations, such as high-frequency chest wall oscillation technology, to enhance mucus clearance effectiveness, improve patient comfort, shorten treatment time, and offer non-invasive, at-home treatment options. This results in improved clinical outcomes and a better quality of life for cystic fibrosis patients. High-frequency chest wall oscillation technology uses rapid air pulses to create vibrations on the chest wall, which helps loosen and mobilize mucus, making it easier to remove from the lungs. For instance, in September 2024, Baxter International Inc., a US-based healthcare company, introduced its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System retains the reliable airflow technology from its predecessor while incorporating enhanced comfort and patient-centric features based on feedback from both clinicians and patients. This system is designed to assist with daily therapy for both adults and children with chronic lung conditions and retained secretions.

In September 2023, Inogen Inc., a US-based medical technology company, acquired Physio-Assist SAS for an undisclosed amount. Through this acquisition, Inogen intends to expand its respiratory care portfolio and address the growing and underserved airway clearance market, particularly with the Simeox device for bronchiectasis and other chronic respiratory conditions. Physio-Assist SAS, based in France, specializes in airway clearance and mucus management devices.

Major players in the airway clearance devices for cystic fibrosis market are Koninklijke Philips N.V., Baxter International Inc., ICU Medical Inc., Vyaire Medical Inc., Tactile Systems Technology Inc., RespirTech, Mercury Medical Inc., Electromed Inc., Vitality Medical Inc., Monaghan Medical Corporation, Pulmodyne Inc., PARI GmbH, Flexicare Limited, D.R. Burton Healthcare Limited, Intersurgical Ltd., Clement Clarke International Ltd., Thayer Medical Inc., AirPhysio, VORTRAN Medical Technology Inc., Med Systems Inc., Wave Healthcare.

North America was the largest region in the airway clearance devices for cystic fibrosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in airway clearance devices for cystic fibrosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the airway clearance devices for cystic fibrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Airway clearance devices for cystic fibrosis are medical instruments designed to assist in clearing mucus from the lungs, thereby improving respiratory function and reducing the likelihood of lung infections. These devices are primarily used to manage respiratory symptoms, boost lung function, and enhance the quality of life for individuals with cystic fibrosis or other chronic respiratory conditions.

The key types of airway clearance devices for cystic fibrosis include vest systems, intrapulmonary percussive ventilators (IPV), positive expiratory pressure (PEP) devices, high-frequency chest wall oscillation (HFCWO) devices, and other related devices. Vest systems are wearable devices that use rapid air pulses to help clear mucus from the lungs. These devices are used by both adult and pediatric patients with cystic fibrosis. They are commonly found in hospitals, clinics, home healthcare settings, and other healthcare environments.

The airway clearance devices for cystic fibrosis market research report is one of a series of new reports that provides airway clearance devices for cystic fibrosis market statistics, including airway clearance devices for cystic fibrosis industry global market size, regional shares, competitors with a airway clearance devices for cystic fibrosis market share, detailed airway clearance devices for cystic fibrosis market segments, market trends and opportunities, and any further data you may need to thrive in the airway clearance devices for cystic fibrosis industry. This airway clearance devices for cystic fibrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The airway clearance devices for cystic fibrosis market consists of sales of incentive spirometers, manual chest physiotherapy (CPT) devices and nebulizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.